Officials in India have introduced a bill that would establish a Central Drugs Authority (CDA)— headed by the secretary of health and family welfare—to regulate drugs and cosmetics. The Drugs and Cosmetics (Amendment) Bill, 2013, intended to replace the 1940 Drugs and Cosmetics Act, would also establish a separate chapter on the clinical trials sector that would introduce penal provisions for the payment of compensation, registration and the creation of ethics committees. Under the proposed legislation, CDA would be able to review, suspend or cancel permission or license for drugs and cosmetics manufacturing. See The Times of India, August 30, 2013.